In this episode of the Oliver Wyman Health Podcast, we share what it's like to be the only female leader in the room, and discuss how digital innovation is advancing social determinants of health.
In the wake of disruption from industries like retail and finance, healthcare incumbents must anticipate disruption from the side or above, not just head-on.
In this video, Terry Stone discusses where disruptive innovation is likely to come from and why.
According to Oliver Wyman’s Consumer Survey of US Healthcare, women are more engaged in their health decisions than men. Healthcare companies must give female consumers the kind of health system they're seeking.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.
Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.
While the Graham-Cassidy bill failed to come to a vote keeping ACA as the law of the land, changes are coming. Here are four ways to react.
Healthcare organizations are working hard to become consumer-centric. To achieve real success, they need to focus on becoming magnetic.
Terry Stone writes in The Hill on the critical need to partner with American businesses during this next phase of health reform.